|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61P 35/00 | |||
| A61K 47/68 | |||
| A61K 39/395 |
| (11) | Patento numeris | 3036257 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14761739.3 |
| Europos patento paraiškos padavimo data | 2014-08-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/051831 |
| Data | 2014-08-20 |
| (87) | Numeris | WO 2015/026907 |
| Data | 2015-02-26 |
| (30) | Numeris | Data | Šalis |
| 201361868185 P | 2013-08-21 | US | |
| 201462012440 P | 2014-06-16 | US | |
| 201462026088 P | 2014-07-18 | US |
| (72) |
PAPADOPOULOS, Nicholas, US
THURSTON, Gavin, US
KIRSHNER, Jessica, US
KELLY, Marcus, US
NITTOLI, Thomas, US
DELFINO, Frank, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTI-PRLR ANTIBODIES AND USES THEREOF |
| ANTI-PRLR ANTIBODIES AND USES THEREOF |